Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT (RIC HSCT NMD)

    ... Alemtuzumab Fludarabine Phase:  ...

    Clinical Trial last updated 06/13/2016 - 2:18pm.

  2. StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

    ... Cyclosporine Filgrastim Fludarabine Mycophenolate Mofetil ...

    Clinical Trial last updated 06/03/2016 - 2:37pm.

  3. Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

    ... Cyclosporine Fludarabine Phase:  ... mg/m2/day IV, day 1 (for CD20+ patients) Drug: Fludarabine Fludarabine:25 mg/m2/day IV, days 1-4 Drug: Cyclosporine Cyclosporine:2 ...

    Clinical Trial last updated 04/28/2016 - 11:28am.

  4. Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

    ... Associated Drug(s):  Fludarabine Mycophenolate Mofetil ... Intervention:  Drug: Fludarabine Days -6 through -2: 30 mg/m^2 IV daily Other Name: Fludara Drug: ...

    Clinical Trial last updated 05/03/2016 - 11:45am.

  5. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... Cyclophosphamide Fludarabine Phase:  ... access device over 2 hours. Other Name: Busulfex Drug: Fludarabine Fludarabine will be given IV in 50-100 ml of D5W or 0.9% sodium ...

    Clinical Trial last updated 05/03/2016 - 10:47am.

  6. Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant

    ... Associated Drug(s):  Fludarabine Mycophenolate Mofetil ... A Neoral OL 27-400 Sandimmun Sandimmune SangCya Drug: Fludarabine Phosphate Given IV Other Names: 2-F-ara-AMP 9H-Purin-6-amine, ...

    Clinical Trial last updated 04/28/2016 - 12:07pm.

  7. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... Associated Drug(s):  Fludarabine Phase:  ... x 1 Drug: Cyclophosphamide 60 mg/ kg/day x 2 (or fludarabine 25mg/m2 x 5 if cyclophosphamide is contraindicated). Drug: ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  8. Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia

    ... Cyclophosphamide Fludarabine Mycophenolate Mofetil ... 138719 Drug: Fludarabine Phosphate Given IV Other Names: 2-F-ara-AMP 9H-Purin-6-amine, ...

    Clinical Trial last updated 04/29/2016 - 12:58pm.

  9. Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation

    ... Cyclophosphamide Fludarabine Phase:  ... Intervention:  Drug: Fludarabine Other Names: Fludara 2-Fluoro-ara-A Monophosphate 2-Fluoro-ara ...

    Clinical Trial last updated 05/03/2016 - 11:15am.

  10. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... Admit to hospital. Line insertion 6 days before transplant Fludarabine (chemotherapy) Cyclophosphamide (chemotherapy) 5 days before transplant Fludarabine Thiotepa 4 days before transplant Fludarabine Thiotepa 3 days ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.